Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 2/2015

01-04-2015 | Research

Identification of Differently Expressed Genes with Specific SNP Loci for Breast Cancer by the Integration of SNP and Gene Expression Profiling Analyses

Authors: Pengfei Yuan, Dechun Liu, Miao Deng, Jiangbo Liu, Jianguang Wang, Like Zhang, Qipeng Liu, Ting Zhang, Yanbin Chen, Gaoyuan Jin

Published in: Pathology & Oncology Research | Issue 2/2015

Login to get access

Abstract

This study aims to explore the relationship between gene polymorphism and breast cancer, and to screen DEGs (differentially expressed genes) with SNPs (single nucleotide polymorphisms) related to breast cancer. The SNPs of 17 patients and the preprocessed SNP profiling GSE 32258 (38 cases of normal breast cells) were combined to identify their correlation with breast cancer using chi-square test. The gene expression profiling batch8_9 (38 cases of patients and 8 cases of normal tissue) was preprocessed with limma package, and the DEGs were filtered out. Then fisher’s method was applied to integrate DEGs and SNPs associated with breast cancer. With NetBox software, TRED (Transcriptional Regulatory Element Database) and UCSC (University of California Santa Cruz) database, genes-associated network and transcriptional regulatory network were constructed using cytoscape software. Further, GO (Gene Ontology) and KEGG analyses were performed for genes in the networks by using siggenes. In total, 332 DEGs were identified. There were 160 breast cancer-related SNPs related to 106 genes of gene expression profiling (19 were significant DEGs). Finally, 11co-correlated DEGs were selected. In genes-associated network, 9 significant DEGs were correlated to 23 LINKER genes while, in transcriptional regulatory network, E2F1 had regulatory relationships with 7 DEGs including MTUS1, CD44, CCNB1 and CCND2. KRAS with SNP locus of rs1137282 was involved in 35 KEGG pathways. The genes of MTUS1, CD44, CCNB1, CCND2 and KRAS with specific SNP loci may be used as biomarkers for diagnosis of breast cancer. Besides, E2F1 was recognized as the transcription factor of 7 DEGs including MTUS1, CD44, CCNB1 and CCND2.
Literature
1.
Sariego J (2010) Breast cancer in the young patient. Am Surg 76(12):1397–1400PubMed
2.
Boyle P, Levin B (2008) World Cancer Report 2008. IARC Press, International Agency for Research on Cancer, Lyon
3.
4.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100(7):3983CrossRefPubMedCentralPubMed
5.
Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422CrossRefPubMed
6.
Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42(6):504–507CrossRefPubMedCentralPubMed
7.
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093CrossRefPubMedCentralPubMed
8.
Zardawi SJ, Zardawi I, McNeil CM, Millar EK, McLeod D, Morey AL, Crea P, Murphy NC, Pinese M, Lopez‐Knowles E (2010) High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype. Histopathology 56(3):286–296CrossRefPubMed
9.
Veronesi A, de Giacomi C, Magri MD, Lombardi D, Zanetti M, Scuderi C, Dolcetti R, Viel A, Crivellari D, Bidoli E (2005) Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases. BMC Cancer 5(1):70CrossRefPubMedCentralPubMed
10.
Satorra A, Bentler PM (2001) A scaled difference chi-square test statistic for moment structure analysis. Psychometrika 66(4):507–514CrossRef
11.
Sanges R, Cordero F, Calogero RA (2007) oneChannelGUI: a graphical interface to Bioconductor tools, designed for life scientists who are not familiar with R language. Bioinformatics 23(24):3406–3408CrossRefPubMed
12.
Whitlock M (2005) Combining probability from independent tests: the weighted Z‐method is superior to Fisher’s approach. J Evol Biol 18(5):1368–1373CrossRefPubMed
13.
Kim H-Y, Byun M-J, Kim H (2011) A replication study of genome-wide CNV association for hepatic biomarkers identifies nine genes associated with liver function. Biochem Mol Biol Rep 44(9):578–583
14.
15.
Wang Y, Wang DD (2013) University of California, Santa Cruz
16.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRefPubMedCentralPubMed
17.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25(1):25–29CrossRefPubMedCentralPubMed
18.
Nakaya A, Katayama T, Itoh M, Hiranuka K, Kawashima S, Moriya Y, Okuda S, Tanaka M, Tokimatsu T, Yamanishi Y (2013) KEGG OC: a large-scale automatic construction of taxonomy-based ortholog clusters. Nucleic Acids Res 41(D1):D353–D357CrossRefPubMedCentralPubMed
19.
Schwender H, Krause A, Ickstadt K (2006) Identifying interesting genes with siggenes. The Newsletter of the R Project Volume 6/5, December 2006 34:45
20.
Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684–1691CrossRefPubMed
21.
Camphausen F, Kohl M, Ruckdeschel P, Stabla T, Ruckdeschel MP (2007) The distr Package
22.
Irizarry RA, Hobbs B, Collin F, Beazer‐Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249–264CrossRefPubMed
23.
Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs, vol 4. World Health Organization
24.
Zuern C, Heimrich J, Kaufmann R, Richter KK, Settmacher U, Wanner C, Galle J, Seibold S (2010) Down-regulation of MTUS1 in human colon tumors. Oncol Rep 23(1):183–189PubMed
25.
Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, Meindl A, Kiechle-Bahat M, Bugert P, Schmutzler RK, Bartram CR (2007) Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28(7):1442–1445CrossRefPubMed
26.
Ye H, Pungpravat N, Huang B-L, Muzio LL, Mariggiò MA, Chen Z, Wong DT, Zhou X (2007) Genomic assessments of the frequent loss of heterozygosity region on 8p21. 3 ∼ p22 in head and neck squamous cell carcinoma. Cancer Genet Cytogenet 176(2):100–106CrossRefPubMedCentralPubMed
27.
Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinie V, Reyal F (2009) 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One 4(10):e7239CrossRefPubMedCentralPubMed
28.
Bajorath J (2000) Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins Struct Funct Bioinforma 39(2):103–111CrossRef
29.
Mayer B, Jauch K, Schildberg F, Funke I, Günthert U, Figdor C, Johnson J (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342(8878):1019–1022CrossRefPubMed
30.
Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14(21):6751–6760CrossRefPubMed
31.
Alvero AB, Chen R, Fu H-H, Montagna M, Schwartz PE, Rutherford T, Silasi D-A, Steffensen KD, Waldstrom M, Visintin I (2009) Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance. Cell Cycle (Georgetown, Tex) 8(1):158CrossRef
32.
Herrera-Gayol A, Jothy S (1999) Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 66(2):149–156CrossRefPubMed
33.
Li Y, Chen Y-L, Xie Y-T, Zheng L-Y, Han J-Y, Wang H, Tian X-X, Fang W-G (2013) Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women. PLoS One 8(12):e84489CrossRefPubMedCentralPubMed
34.
French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O’Reilly M, Hillman KM (2013) Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 92(4):489–503CrossRefPubMedCentralPubMed
35.
Song H, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D (2008) Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res 14(4):1090–1095CrossRefPubMedCentralPubMed
36.
Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BA, Easton DF, Pharoah PD, Dunning AM (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29(2):333–341CrossRefPubMedCentralPubMed
37.
Johnson DG (2000) The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog 27(3):151–157CrossRefPubMed
38.
Abdraboh ME, Gaur RL, Hollenbach AD, Sandquist D, Raj MH, Ouhtit A (2011) Survivin is a novel target of CD44-promoted breast tumor invasion. Am J Pathol 179(2):555–563CrossRefPubMedCentralPubMed
39.
Huang L (2008) Carrot and stick: HIF-α engages c-Myc in hypoxic adaptation. Cell Death Differ 15(4):672–677CrossRefPubMed
40.
Wang WY, Chien YC, Wong YK, Lin YL, Lin JC (2012) Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma. Head Neck 34(5):663–666CrossRefPubMed
41.
Yen L-C, Yeh Y-S, Chen C-W, Wang H-M, Tsai H-L, Lu C-Y, Chang Y-T, Chu K-S, Lin S-R, Wang J-Y (2009) Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 15(13):4508–4513CrossRefPubMed
Metadata
Title
Identification of Differently Expressed Genes with Specific SNP Loci for Breast Cancer by the Integration of SNP and Gene Expression Profiling Analyses
Authors
Pengfei Yuan
Dechun Liu
Miao Deng
Jiangbo Liu
Jianguang Wang
Like Zhang
Qipeng Liu
Ting Zhang
Yanbin Chen
Gaoyuan Jin
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9851-1

Other articles of this Issue 2/2015

Pathology & Oncology Research 2/2015 Go to the issue

Research

Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer

Research

Prolactin and Prolactin Receptor Expression in Cervical Intraepithelial Neoplasia and Cancer

Research

Overexpression of Autophagy-Related 16-Like 1 in Patients with Oral Squamous Cell Carcinoma

Research

Prognostic Value of Ki-67 in Breast Carcinoma: Tissue Microarray Method Versus Whole Section Analysis- Potentials and Pitfalls

Research

Replication Study for the Association of Seven Genome- Gwas-Identified Loci With Susceptibility to Ovarian Cancer in the Polish Population

Letter to Editor

Hybrid Odontogenic Tumors: A Controversy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits